
High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Size: Market Cap wise it is among the top 20% companies of india.
Insider Trading: There's significant insider buying recently.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Profitability: Recent profitability of 8% is a good sign.
Technicals: Bullish SharesGuru indicator.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Growth: Good revenue growth. With NA% growth over past three years, the company is going strong.
Balance Sheet: Strong Balance Sheet.
Dividend: Stock hasn't been paying any dividend.
Valuation | |
|---|---|
| Market Cap | 14.56 kCr |
| Price/Earnings (Trailing) | 72.88 |
| Price/Sales (Trailing) | 5.88 |
| EV/EBITDA | 45.85 |
| Price/Free Cashflow | 108.74 |
| MarketCap/EBT | 56.57 |
| Enterprise Value | 14.44 kCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 2.48 kCr |
| Rev. Growth (Yr) | 21.9% |
| Earnings (TTM) | 200.19 Cr |
| Earnings Growth (Yr) | 178% |
Profitability | |
|---|---|
| Operating Margin | 11% |
| EBT Margin | 10% |
| Return on Equity | 14.18% |
| Return on Assets | 9.57% |
| Free Cashflow Yield | 0.92% |
Growth & Returns | |
|---|---|
| Price Change 1W | -4.2% |
| Price Change 1M | 7.6% |
| Price Change 6M | 64.6% |
| Price Change 1Y | 62.6% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | -17.06 Cr |
| Cash Flow from Operations (TTM) | 141.35 Cr |
| Cash Flow from Financing (TTM) | -38.03 Cr |
| Cash & Equivalents | 119.22 Cr |
| Free Cash Flow (TTM) | 133.91 Cr |
| Free Cash Flow/Share (TTM) | 4.12 |
Balance Sheet | |
|---|---|
| Total Assets | 2.09 kCr |
| Total Liabilities | 680.64 Cr |
| Shareholder Equity | 1.41 kCr |
| Current Assets | 958.94 Cr |
| Current Liabilities | 568.34 Cr |
| Net PPE | 135.72 Cr |
| Inventory | 165.05 Cr |
| Goodwill | 172.47 Cr |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.00 |
| Debt/Equity | 0.00 |
| Interest Coverage | 18.59 |
| Interest/Cashflow Ops | 11.76 |
Dividend & Shareholder Returns | |
|---|---|
| Shares Dilution (1Y) | 0.10% |
Size: Market Cap wise it is among the top 20% companies of india.
Insider Trading: There's significant insider buying recently.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Profitability: Recent profitability of 8% is a good sign.
Technicals: Bullish SharesGuru indicator.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Growth: Good revenue growth. With NA% growth over past three years, the company is going strong.
Balance Sheet: Strong Balance Sheet.
Dividend: Stock hasn't been paying any dividend.
Investor Care | |
|---|---|
| Shares Dilution (1Y) | 0.10% |
| Earnings/Share (TTM) | 6.14 |
Financial Health | |
|---|---|
| Current Ratio | 1.69 |
| Debt/Equity | 0.00 |
Technical Indicators | |
|---|---|
| RSI (14d) | 36.6 |
| RSI (5d) | 15.52 |
| RSI (21d) | 60.13 |
| MACD Signal | Sell |
| Stochastic Oscillator Signal | Hold |
| SharesGuru Signal | Buy |
| RSI Signal | Hold |
| RSI5 Signal | Buy |
| RSI21 Signal | Hold |
| SMA 5 Signal | Sell |
| SMA 10 Signal | Sell |
| SMA 20 Signal | Sell |
| SMA 50 Signal | Buy |
| SMA 100 Signal | Buy |
Summary of Honasa Consumer's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Management provided an optimistic outlook for Honasa Consumer Limited, emphasizing sustained growth and expansion strategies for the upcoming fiscal year and beyond. The company recorded a robust 28% year-over-year growth in Q4 FY '26, coupled with a nearly 2.5x increase in EBITDA compared to the same quarter last year. Quarterly revenue reached INR 682 crores, with an EBITDA of INR 77 crores reflecting an 11.3% margin. The net profit after tax (PAT) stood at INR 69 crores at a margin of 10.2%.
Key forward-looking points include management's expectation of high-teens CAGR over the next five years, driven by distribution gains and capturing market share across focus categories. Notably, Mamaearth is projected to achieve a double-digit CAGR over the next five years, with plans to grow its distribution from 200,000 to potentially 500,000 outlets. The strategic focus remains on core and newer categories, particularly skincare and nutraceuticals, with a strong emphasis on premiumization.
Management also highlighted the successful integration of Reginald Men, which has doubled its revenue year-over-year and crossed INR 100 crores ARR. The Derma Co brand is performing well, boasting a substantial ARR of INR 750 crores, and continues to expand its market share in active ingredients. The company plans to reward shareholders with a dividend of INR 3 per equity share, highlighting strong cash generation capabilities.
Overall, the management's confidence in growth prospects is underpinned by strategic brand positioning, expanding product offerings, and a commitment to shareholder returns amidst a robust consumer demand landscape.
Question 1: Vivek from Jefferies India:
"Given the size of the Mamaearth brand and the penetration-led opportunity in the offline space, how do you see this brand growing in FY '27 and over the next three years?"
Answer:
"I am confident we can achieve a double-digit CAGR for Mamaearth over the next five years. We see significant share gain opportunities, especially in face wash and shampoo categories. Currently present in 200,000 outlets, we aim to expand this to 500,000. This combination of growth in share and distribution makes me optimistic about the brand's trajectory."
Question 2: Vivek from Jefferies India:
"With your entry into men's skincare and nutraceuticals, do you see these new initiatives complicating operations?"
Answer:
"Men's skincare remains aligned with our core skincare categories. As opportunities arise, we'll adapt our organizational structure accordingly. I believe our team can successfully integrate these new initiatives without losing focus on existing categories. We aim to capture emerging markets by incorporating the necessary talent to support growth profitably."
Question 3: Vivek from Jefferies India:
"Is it true that TDC has performed significantly better than Aqualogica this quarter? What are the reasons for Aqualogica's performance?"
Answer:
"TDC has indeed exceeded initial expectations and is positioned for significant growth, aiming for INR 1,000 crores revenue. Aqualogica, being younger, is still developing its market presence. Each brand's trajectory is different, influenced by consumer sentiment and our strategic focus on active ingredients currently favoring TDC."
Question 4: Manoj Menon from ICICI Securities:
"What portion of growth is attributed to new products launched in the past year compared to existing products?"
Answer:
"New products launched in the last year contributed approximately 7% to 8% of our growth. We're now looking at a three-year horizon for assessing product innovations, as we aim for meaningful market penetration over time rather than short-term gains."
Question 5: Manoj Menon from ICICI Securities:
"Can you share insights about Reginald Men since its acquisition and its growth potential?"
Answer:
"Reginald Men has significant growth potential, primarily in expanding distribution and category diversification beyond sunscreens. We're enhancing category offerings, and currently targeting broader markets like Maharashtra. We are optimistic about leveraging these new approaches to drive future growth."
Question 6: Umang Shah from Banyan Tree Advisors PMS:
"Can you explain the discrepancy between advertising expenses growth and other expenses decreasing?"
Answer:
"Advertising is increasing in value but reducing as a percentage of revenue, reflecting operational leverage. We aim to improve our EBITDA by managing channel, brand, and operational spend strategically, focusing on where we can generate the most growth and margin."
Question 7: Nitin from HDFC Securities:
"What is your stance on inflation's impact and plans for price hikes?"
Answer:
"We've adjusted prices to mitigate impact from crude price fluctuations. Price increases are executed cautiously to ensure competitiveness. We don't anticipate further hikes currently as we believe our pricing adjustments will sufficiently handle cost inflation."
Question 8: Yogeeta from Aditya Birla Capital:
"What strategies do you have for driving premiumization in skincare and haircare?"
Answer:
"Our strategy embraces premiumization to serve the emerging middle class with aspirational brands. This trend is expected to evolve over decades, fueling future growth and margin improvements across our product offerings."
Question 9: Yogeeta from Aditya Birla Capital:
"What are your margin expectations for core brands like Mamaearth and Derma Co. for FY '27?"
Answer:
"Both Mamaearth and Derma Co. are currently achieving double-digit EBITDA margins. We expect this trajectory to continue, with plans for a 500-basis-point improvement in EBITDA margins overall over the next five years."
Question 10: Yogeeta from Aditya Birla Capital:
"How do you expect the young brands and focus categories to perform in FY '27?"
Answer:
"The young brands are set to drive strong growth next year, as over 90% of our investments are channeled into our focus categories, ensuring sustained momentum in these core areas."
Understand Honasa Consumer ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| VARUN ALAGH | 32.38% |
| PEAK XV PARTNERS INVESTMENTS VI | 14.8% |
| ICICI PRUDENTIAL LIFE INSURANCE COMPANY LIMITED | 6.26% |
| SEQUOIA CAPITAL GLOBAL GROWTH FUND III - U.S./INDI | 3.44% |
| GHAZAL ALAGH | 3.06% |
| HDFC LIFE INSURANCE COMPANY LIMITED | 2.74% |
| IROHA EMERGING INDIA FUND-I | 1.85% |
| AROHI EMERGING INDIA MASTER FUND | 1.75% |
| MAP INSTITUTIONAL LLC - MAP INSTITUTIONAL LLC 804 | 1.41% |
| STELLARIS VENTURE PARTNERS INDIA I | 1.36% |
| BANDHAN LARGE & MID CAP FUND | 1.34% |
| FRANKLIN TEMPLETON INVESTMENT FUNDS - TEMPLETON AS | 1.22% |
| MIRAE ASSET NIFTY500 MULTICAP 50:25:25 ETF | 1.06% |
| JASPAL ALAGH | 0.02% |
| MUKESH ALAGH | 0.02% |
| SUNITA SAHNI | 0% |
| KAILASH SAHANI | 0% |
| CHIRAG SAHANI | 0% |
| SAHIBA CHAUHAN | 0% |
| KAILASH SAHNI & FAMILY HUF | 0% |
Distribution across major stakeholders
Distribution across major institutional holders
Detailed comparison of Honasa Consumer against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| HINDUNILVR | Hindustan Unilever | 5.04 LCr | 66.3 kCr | -0.50% | -12.00% | 33.53 | 7.61 | - | - |
| MARICO | Marico | 1.11 LCr | 13.81 kCr | +4.60% | +21.20% | 62.88 | 8.05 | - | - |
| GODREJCP | Godrej Consumer Products | 1.08 LCr | 15.76 kCr | +3.80% | -13.50% | 58.22 | 6.88 | - | - |
| DABUR | Dabur India | 75.1 kCr | 13.79 kCr | -0.20% | -17.40% | 39.61 | 5.44 | - | - |
| EMAMILTD | Emami | 17.77 kCr | 3.86 kCr | +0.70% | -29.80% | 22.93 | 4.6 | - | - |
Comprehensive comparison against sector averages
HONASA metrics compared to Personal
| Category | HONASA | Personal |
|---|---|---|
| PE | 72.55 | 43.17 |
| PS | 5.85 | 6.58 |
| Growth | 15.4 % | 7.6 % |
Honasa Consumer Limited operates as a digital-first beauty and personal care company in India and internationally. The company provides face care, body care and personal wash, hair care, suncare, color cosmetics, baby care, and fragrance products under Mamaearth, The Derma Co., Aqualogica, Ayuga, Staze and Dr. Sheth's brands. It offers beauty salon and hair styling services under the BBlunt brand; and Momspresso, a content development and influencer marketing platform. The company was formerly known as Honasa Consumer Private Limited and changed its name to Honasa Consumer Limited in November 2022.Honasa Consumer Limited was incorporated in 2016 and is based in Gurugram, India.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
HONASA vs Personal (2024 - 2026)